SCHEMBL10073361

SCHEMBL10073361

CC(C)(C)OC(=O)CCS[C@@H]1C(CC2CCCC2)N(S(=O)(=O)c2ccc(Cl)cc2)C(c2ccc(Cl)cc2)[C@@H]1C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RABGGTB P53611 9/20 1.00
RABGGTA Q92696 9/20 1.00
FNTA P49354 1/20 0.35
PGGT1B P53609 1/20 0.35
APP P05067 1/20 0.34
PSEN1 P49768 5/20 0.33
PSEN2 P49810 5/20 0.33
APH1B Q8WW43 5/20 0.33
NCSTN Q92542 5/20 0.33
APH1A Q96BI3 5/20 0.33
PSENEN Q9NZ42 5/20 0.33
ACHE P22303 1/20 0.33
CYP3A4 P08684 1/20 0.33
STS P08842 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA4 P22748 1/20 0.33
CA7 P43166 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10047259 1.00 RABGGTB (1.00) RABGGTBRABGGTAFNTAPGGT1BAPP
SCHEMBL10073357 0.97 RABGGTB (1.00) RABGGTBRABGGTAFNTAPGGT1BAPP
SCHEMBL10047260 0.97 RABGGTB (1.00) RABGGTBRABGGTAFNTAPGGT1BAPP
SCHEMBL10047253 0.90 RABGGTB (0.85) RABGGTBRABGGTAFNTAPGGT1B
SCHEMBL10073371 0.90 RABGGTB (0.85) RABGGTBRABGGTAFNTAPGGT1B
SCHEMBL10047250 0.89 RABGGTB (0.83) RABGGTBRABGGTA
SCHEMBL10073599 0.89 RABGGTB (0.83) RABGGTBRABGGTA
SCHEMBL10073370 0.88 RABGGTB (1.00) RABGGTBRABGGTAPSEN1PSEN2APH1B
SCHEMBL10047265 0.88 RABGGTB (1.00) RABGGTBRABGGTAPSEN1PSEN2APH1B
SCHEMBL10072791 0.87 RABGGTB (0.77) RABGGTBRABGGTAFNTAPGGT1BAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093274-B2 Inhibitors of protein prenyltransferases THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-01-10 US disclosed
US-20100063114-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100063114-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES GGT1, FNTA, FNTB RABGGTB 17/4885RABGGTA 5/4885FNTA 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.